Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Bille

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Intensive Care Medicine|February 22, 2018
Correction to: Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemiaLauro Damonti, Véronique Erard, Jorge Garbino, et al.
Intensive Care Medicine|March 9, 2017
Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemiaLauro Damonti, Véronique Erard, Jorge Garbino, et al.
Foodborne Pathogens and Disease|October 14, 2008
Characterization of human invasive isolates of Listeria monocytogenes in Sweden 1986-2007Vishal Singh Parihar, Gloria Lopez-Valladares, Marie-Louise Danielsson-Tham, et al.
The Journal of Infection|January 30, 2018
Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS studyChristina Orasch, Dominik Mertz, Jorge Garbino, et al.
Diagnostic Microbiology and Infectious Disease|March 27, 2010
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance ProgramMichael A Pfaller, Daniel J Diekema, David L Gibbs, et al.
Journal of Clinical Microbiology|August 7, 2004
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesFrank C Odds, Mary Motyl, Roberto Andrade, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupBen De Pauw, Thomas J Walsh, J Peter Donnelly, et al.
Journal of the American College of Cardiology|November 30, 2019
Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve ReplacementSylvain Beurtheret, Nicole Karam, Noemie Resseguier, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Intensive Care Medicine|February 22, 2018
Correction to: Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemiaLauro Damonti, Véronique Erard, Jorge Garbino, et al.
Intensive Care Medicine|March 9, 2017
Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemiaLauro Damonti, Véronique Erard, Jorge Garbino, et al.
Foodborne Pathogens and Disease|October 14, 2008
Characterization of human invasive isolates of Listeria monocytogenes in Sweden 1986-2007Vishal Singh Parihar, Gloria Lopez-Valladares, Marie-Louise Danielsson-Tham, et al.
The Journal of Infection|January 30, 2018
Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS studyChristina Orasch, Dominik Mertz, Jorge Garbino, et al.
Diagnostic Microbiology and Infectious Disease|March 27, 2010
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance ProgramMichael A Pfaller, Daniel J Diekema, David L Gibbs, et al.
Journal of Clinical Microbiology|August 7, 2004
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesFrank C Odds, Mary Motyl, Roberto Andrade, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2008
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaBrahm H Segal, Raoul Herbrecht, David A Stevens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupBen De Pauw, Thomas J Walsh, J Peter Donnelly, et al.
Journal of the American College of Cardiology|November 30, 2019
Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve ReplacementSylvain Beurtheret, Nicole Karam, Noemie Resseguier, et al.
Pageof 9